Treatment planning comparison for head and neck cancer between photon, proton, and combined proton-photon therapy - from a fixed beam line to an arc.

Amstutz, Florian; Krcek, Reinhardt; Bachtiary, Barbara; Weber, Damien C; Lomax, Antony J; Unkelbach, Jan; Zhang, Ye (2024). Treatment planning comparison for head and neck cancer between photon, proton, and combined proton-photon therapy - from a fixed beam line to an arc. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 190(109973), p. 109973. Elsevier Scientific Publ. Ireland 10.1016/j.radonc.2023.109973

[img]
Preview
Text
1-s2.0-S016781402389867X-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (5MB) | Preview

BACKGROUND AND PURPOSE

This study investigates whether combined proton-photon therapy (CPPT) improves treatment plan quality compared to single-modality intensity-modulated radiation therapy (IMRT) or intensity-modulated proton therapy (IMPT) for head and neck cancer (HNC) patients. Different proton beam arrangements for CPPT and IMPT are compared, which could be of specific interest concerning potential future upright-positioned treatments. Furthermore, it is evaluated if CPPT benefits remain under inter-fractional anatomical changes for HNC treatments.

MATERIAL AND METHODS

Five HNC patients with a planning CT and multiple (4-7) repeated CTs were studied. CPPT with simultaneously optimized photon and proton fluence, single-modality IMPT, and IMRT treatment plans were optimized on the planning CT and then recalculated and reoptimized on each repeated CT. For CPPT and IMPT, plans with different degrees of freedom for the proton beams were optimized. Fixed horizontal proton beam line (FHB), gantry-like, and arc-like plans were compared.

RESULTS

The target coverage for CPPT without adaptation is insufficient (average V95%=88.4%), while adapted plans can recover the initial treatment plan quality for target (average V95%=95.5%) and organs-at-risk. CPPT with increased proton beam flexibility increases plan quality and reduces normal tissue complication probability of Xerostomia and Dysphagia. On average, Xerostomia NTCP reductions compared to IMRT are -2.7%/-3.4%/-5.0% for CPPT FHB/CPPT Gantry/CPPT Arc. The differences for IMPT FHB/IMPT Gantry/IMPT Arc are +0.8%/-0.9%/-4.3%.

CONCLUSION

CPPT for HNC needs adaptive treatments. Increasing proton beam flexibility in CPPT, either by using a gantry or an upright-positioned patient, improves treatment plan quality. However, the photon component is substantially reduced, therefore, the balance between improved plan quality and costs must be further determined.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Krcek, Reinhardt, Weber, Damien Charles

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1879-0887

Publisher:

Elsevier Scientific Publ. Ireland

Language:

English

Submitter:

Pubmed Import

Date Deposited:

06 Nov 2023 11:21

Last Modified:

20 Feb 2024 00:13

Publisher DOI:

10.1016/j.radonc.2023.109973

PubMed ID:

37913953

Uncontrolled Keywords:

Combined proton-photon therapy arc therapy head and neck photon therapy proton therapy

BORIS DOI:

10.48350/188502

URI:

https://boris.unibe.ch/id/eprint/188502

Actions (login required)

Edit item Edit item
Provide Feedback